Camlin Fine Sciences Faces ₹5.47 Cr Tax Demand, Plans Appeal

Camlin Fine Sciences Limited announced on April 10, 2026, that it has received a tax demand notice for ₹5.47 crore from the Income Tax Department. This demand pertains to Assessment Year 2023-24 and is linked to adjustments made on the Arm's Length Price for transactions with associated entities.

The company has assured investors that the notice will not affect its financial or operational activities. Camlin Fine Sciences plans to file an appeal against the Income Tax Department's order.

Previous Tax Issues Add to Scrutiny

This latest demand follows a series of tax-related notices. In March 2026, the company disclosed receiving a ₹47.08 crore tax demand, including penalties, for alleged ineligible Input Tax Credit (ITC) over several years. Around the same time, another ₹1.93 crore demand was issued for alleged non-payment of GST under the Reverse Charge Mechanism (RCM) on foreign currency expenses. Camlin Fine Sciences has consistently maintained that these past issues do not materially impact its operations and has pursued appeals.

Investor Watchpoints

While the company is contesting the demand and states no immediate operational impact, such tax disputes can introduce investor uncertainty. Shareholders will be looking for updates on the appeal process. The company's financial projections may also need to consider potential contingencies related to these tax matters. The outcome of the appeal against the ₹5.47 crore demand will be a key point to watch, as an adverse decision could lead to a financial outflow. A continued pattern of tax demands could also invite deeper scrutiny from tax authorities and potentially strain management's bandwidth.

Company Performance Snapshot

For context, Camlin Fine Sciences reported a standalone net loss of ₹36.23 crore for the quarter ended March 31, 2026 (Q3 FY26). Its standalone revenue for the same period was ₹457.20 crore.

Specialty Chemicals Sector Peers

Operating in the specialty chemicals sector, Camlin Fine Sciences competes with established players such as Aarti Industries Ltd., Navin Fluorine International Ltd., and SRF Ltd. These competitors often have stronger financial foundations and have generally faced fewer frequent tax disputes, maintaining consistent growth and operational efficiencies.